Concepedia

Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol

Helen Swaisland, Malcolm Ranson, Robert P. Smith, Joanna Leadbetter, Alison Laight, David McKillop, Martin Wild

Clinical Pharmacokinetics · 2005 · 155 citations · 14 references

DOI

Concepts

References

14

Goodman and Gilman's the Pharmacological Basis of Therapeutics

William H. Stigelman, D Pharm · Military Medicine · 1986 · 6.8K citations

, , +6

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial

Malcolm Ranson, Lisa A. Hammond, D. K. Ferry et al. · Journal of Clinical Oncology · 2002 · 763 citations

, , +14

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

Anu Varhe, Klaus T. Olkkola, Pertti J. Neuvonen · Clinical Pharmacology & Therapeutics · 1994 · 280 citations

, , +15

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin

Janne T. Backman, Kari T. Kivistö, Klaus T. Olkkola et al. · European Journal of Clinical Pharmacology · 1998 · 269 citations

, , +13

Use of in vitro human metabolism studies in drug development

A. David Rodrigues · Biochemical Pharmacology · 1994 · 143 citations

, , +12